Financials

Annual Reports

Financial Reports

Fiscal Year First Quarter Second Quarter Third Quarter Information Circular Financials & MD&A Annual Report

Filings

SEDAR View our filings as a publicly listed company in Canada (TSX).

EDGAR Our SEC filings as a publicly listed company in the United States (NASDAQ).

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Latest News

February 18, 2015 Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Colorectal Cancer Study
February 17, 2015 Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Pancreatic Cancer
February 11, 2015 Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Ovarian Cancer
Sign up to receive e-mail updates *